headphones
Hyperliquid adds full on-chain validator voting function for asset removal
浅蓝加深蓝
浅蓝加深蓝
authIcon
加密先锋
03-29 01:13
Follow
Focus
1. Hyperliquid宣布区块链升级,增添资产移除的全链上验证器投票功能,达到足够票数移除操作自动链上执行。 2. 基于股权的无许可投票加权机制原生集成在HyperCore,无需链下协调技术。 3. 作为机制示范,2025年3月29日21:00左右,Hyper Foundation验证器2 - 5将投票决定是否移除MYRO合约。 4. Hyper Foundation验证器1在参与者初始委托完成前将弃权 。
Helpful
Not Helpful
Play
According to official news, Hyperliquid announced that its blockchain has been upgraded, adding a full-on-chain validator voting function for asset removal. When sufficient voting is reached for removal, the operation will automatically trigger on-chain execution. This equity-based permissionless voting weighting mechanism is natively integrated in HyperCore and does not require off-chain coordination in technology. As a demonstration of this mechanism, Hyper Foundation validators 2-5 will vote at around 21:00 Beijing time on March 29, 2025 to decide whether to remove the MYRO contract. Hyper Foundation Validator 1 will abstain from the vote before the initial delegation of the participants in the delegation is completed.
Open the app to read the full article
DisclaimerAll content on this website, hyperlinks, related applications, forums, blog media accounts, and other platforms published by users are sourced from third-party platforms and platform users. BiJieWang makes no warranties of any kind regarding the website and its content. All blockchain-related data and other content on the website are for user learning and research purposes only, and do not constitute investment, legal, or any other professional advice. Any content published by BiJieWang users or other third-party platforms is the sole responsibility of the individual, and has nothing to do with BiJieWang. BiJieWang is not responsible for any losses arising from the use of information on this website. You should use the related data and content with caution and bear all risks associated with it. We strongly recommend that you independently research, review, analyze, and verify the content.
Comments(0)

No comments yet

edit
comment
collection
like
share